US › Healthcare

MiMedx Group Inc (MDXG)

US · Healthcare · Biotechnology

$4.270.00%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$64.4M
Revenue YoY
-34.7%
Net profit
$-14.8M
Profit YoY
-254.3%
EPS
$-0.05
EPS estimate
$-0.03
Net margin
-23.1%

EPS came in at -0.05 against a street estimate of -0.03 — a miss of 66.7%.

Key statistics

Market cap
$602.0M
P/E
103.2
Forward P/E
19.5
P/B
2.79
Book value
$1.63
EPS (TTM)
$0.04
52-week high
$7.97
52-week low
$3.03
50-day MA
$3.92
200-day MA
$5.06
Beta
1.45

Analyst view

Analysts rate MiMedx Group Inc a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $6.60.

Shareholding

Insiders
2.14%
Institutions
78.42%

Largest institutional holders

FundStake
Essex Woodlands Health Ventures19.34%
BlackRock Inc8.17%
Trigran Investments Inc4.92%
Vanguard Capital Management, LLC3.54%
State Street Corp3.47%
Paradigm Capital Management, Inc.2.34%
Nantahala Capital Management, LLC2.33%
Renaissance Technologies Corp2.07%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for MiMedx Group Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.